Literature DB >> 16585602

Substance P stimulates cyclooxygenase-2 and prostaglandin E2 expression through JAK-STAT activation in human colonic epithelial cells.

Hon-Wai Koon1, Dezheng Zhao, Yanai Zhan, Sang Hoon Rhee, Mary P Moyer, Charalabos Pothoulakis.   

Abstract

Substance P (SP) via its neurokinin-1 receptor (NK-1R) regulates several gastrointestinal functions. We previously reported that NK-1R-mediated chloride secretion in the colon involves formation of PG. PGE2 biosynthesis is controlled by cyclooxygenase-1 (COX-1) and COX-2, whose induction involves the STATs. In this study, we examined whether SP stimulates PGE2 production and COX-2 expression in human nontransformed NCM460 colonocytes stably transfected with the human NK-1R (NCM460-NK-1R cells) and identified the pathways involved in this response. SP exposure time and dose dependently induced an early (1-min) phosphorylation of JAK2, STAT3, and STAT5, followed by COX-2 expression and PGE2 production by 2 h. Pharmacologic experiments showed that PGE2 production is dependent on newly synthesized COX-2, but COX-1 protein. Inhibition of protein kinase Ctheta (PKCtheta), but not PKCepsilon and PKCdelta, significantly reduced SP-induced COX-2 up-regulation, and JAK2, STAT3, and STAT5 phosphorylation. Pharmacological blockade of JAK inhibited SP-induced JAK2, STAT3, and STAT5 phosphorylation; COX-2 expression; and PGE2 production. Transient transfection with JAK2 short-interferring RNA reduced COX-2 promoter activity and JAK2 phosphorylation, while RNA interference of STAT isoforms showed that STAT5 predominantly mediates SP-induced COX-2 promoter activity. Site-directed mutation of STAT binding sites on the COX-2 promoter completely abolished COX-2 promoter activity. Lastly, COX-2 expression was elevated in colon of mice during experimental colitis, and this effect was normalized by administration of the NK-1R antagonist CJ-12,255. Our results demonstrate that SP stimulates COX-2 expression and PGE2 production in human colonocytes via activation of the JAK2-STAT3/5 pathway.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16585602      PMCID: PMC2593099          DOI: 10.4049/jimmunol.176.8.5050

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  57 in total

1.  Epidermal growth factor receptor activation induces nuclear targeting of cyclooxygenase-2, basolateral release of prostaglandins, and mitogenesis in polarizing colon cancer cells.

Authors:  R J Coffey; C J Hawkey; L Damstrup; R Graves-Deal; V C Daniel; P J Dempsey; R Chinery; S C Kirkland; R N DuBois; T L Jetton; J D Morrow
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

Review 2.  Distinct functions of COX-1 and COX-2.

Authors:  Ikuo Morita
Journal:  Prostaglandins Other Lipid Mediat       Date:  2002-08       Impact factor: 3.072

3.  Effects of PGE2 in guinea pig colonic myenteric ganglia.

Authors:  Brian P Manning; Keith A Sharkey; Gary M Mawe
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2002-08-21       Impact factor: 4.052

4.  The acute antihyperalgesic action of nonsteroidal, anti-inflammatory drugs and release of spinal prostaglandin E2 is mediated by the inhibition of constitutive spinal cyclooxygenase-2 (COX-2) but not COX-1.

Authors:  T L Yaksh; D M Dirig; C M Conway; C Svensson; Z D Luo; P C Isakson
Journal:  J Neurosci       Date:  2001-08-15       Impact factor: 6.167

5.  Protective effects of neurokinin-1 receptor during colitis in mice: role of the epidermal growth factor receptor.

Authors:  I Castagliuolo; O Morteau; A C Keates; L Valenick; C-C Wang; J Zacks; B Lu; N P Gerard; C Pothoulakis
Journal:  Br J Pharmacol       Date:  2002-05       Impact factor: 8.739

Review 6.  Prostaglandin biology in inflammatory bowel disease.

Authors:  J L Wallace
Journal:  Gastroenterol Clin North Am       Date:  2001-12       Impact factor: 3.806

7.  Substance P-stimulated interleukin-8 expression in human colonic epithelial cells involves Rho family small GTPases.

Authors:  Dezheng Zhao; Sabina Kuhnt-Moore; Huiyan Zeng; Amy Pan; Jack S Wu; Simos Simeonidis; Mary P Moyer; Charalabos Pothoulakis
Journal:  Biochem J       Date:  2002-12-01       Impact factor: 3.857

8.  Substance P-evoked Cl(-) secretion in guinea pig distal colonic epithelia: interaction with PGE(2).

Authors:  Yutaka Hosoda; Shin-Ichiro Karaki; Yukiko Shimoda; Atsukazu Kuwahara
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2002-08       Impact factor: 4.052

9.  Involvement of the protein kinase C pathway in thyrotropin-induced STAT3 activation in FRTL-5 thyroid cells.

Authors:  Y J Park; E S Park; M S Kim; T Y Kim; H S Lee; S Lee; I S Jang; M Shong; D J Park; Bo Youn Cho
Journal:  Mol Cell Endocrinol       Date:  2002-08-30       Impact factor: 4.102

10.  Expression of the EP4 prostaglandin E2 receptor subtype with rat dextran sodium sulphate colitis: colitis suppression by a selective agonist, ONO-AE1-329.

Authors:  M Nitta; I Hirata; K Toshina; M Murano; K Maemura; N Hamamoto; S Sasaki; H Yamauchi; K Katsu
Journal:  Scand J Immunol       Date:  2002-07       Impact factor: 3.487

View more
  37 in total

Review 1.  JAK-STAT pathway in carcinogenesis: is it relevant to cholangiocarcinoma progression?

Authors:  Olga V Smirnova; Tatiana Yu Ostroukhova; Roman L Bogorad
Journal:  World J Gastroenterol       Date:  2007-12-28       Impact factor: 5.742

Review 2.  Tachykinins and their receptors: contributions to physiological control and the mechanisms of disease.

Authors:  Martin S Steinhoff; Bengt von Mentzer; Pierangelo Geppetti; Charalabos Pothoulakis; Nigel W Bunnett
Journal:  Physiol Rev       Date:  2014-01       Impact factor: 37.312

3.  Substance P induces CCN1 expression via histone deacetylase activity in human colonic epithelial cells.

Authors:  Hon Wai Koon; David Q Shih; Tressia C Hing; Jeremy Chen; Samantha Ho; Dezheng Zhao; Stephan R Targan; Charalabos Pothoulakis
Journal:  Am J Pathol       Date:  2011-09-23       Impact factor: 4.307

4.  The proximodistal aggravation of colitis depends on substance P released from TRPV1-expressing sensory neurons.

Authors:  Matthias A Engel; Mohammad Khalil; Sonja M Mueller-Tribbensee; Christoph Becker; Winfried L Neuhuber; Markus F Neurath; Peter W Reeh
Journal:  J Gastroenterol       Date:  2011-11-12       Impact factor: 7.527

5.  Substance P modulates colitis-associated fibrosis.

Authors:  Hon Wai Koon; David Shih; Iordanes Karagiannides; Dezheng Zhao; Zafeer Fazelbhoy; Tressia Hing; Hua Xu; Bao Lu; Norma Gerard; Charalabos Pothoulakis
Journal:  Am J Pathol       Date:  2010-10-01       Impact factor: 4.307

6.  Transcription factor Ets-1 inhibits glucose-stimulated insulin secretion of pancreatic β-cells partly through up-regulation of COX-2 gene expression.

Authors:  Xiong-Fei Zhang; Yi Zhu; Wen-Biao Liang; Jing-Jing Zhang
Journal:  Endocrine       Date:  2013-11-28       Impact factor: 3.633

7.  Caveolin-1 regulates human immunodeficiency virus-1 Tat-induced alterations of tight junction protein expression via modulation of the Ras signaling.

Authors:  Yu Zhong; Eric J Smart; Babette Weksler; Pierre-Olivier Couraud; Bernhard Hennig; Michal Toborek
Journal:  J Neurosci       Date:  2008-07-30       Impact factor: 6.167

8.  N-oleoyldopamine, a novel endogenous capsaicin-like lipid, protects the heart against ischemia-reperfusion injury via activation of TRPV1.

Authors:  Beihua Zhong; Donna H Wang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-06-20       Impact factor: 4.733

9.  An FDA approved neurokinin-1 receptor antagonist is effective in reducing intraabdominal adhesions when administered intraperitoneally, but not orally.

Authors:  Rizal Lim; Jonathan M Morrill; Scott G Prushik; Karen L Reed; Adam C Gower; Susan E Leeman; Arthur F Stucchi; James M Becker
Journal:  J Gastrointest Surg       Date:  2008-08-16       Impact factor: 3.452

10.  Substance P-mediated expression of the pro-angiogenic factor CCN1 modulates the course of colitis.

Authors:  Hon-Wai Koon; Dezheng Zhao; Hua Xu; Collin Bowe; Alan Moss; Mary P Moyer; Charalabos Pothoulakis
Journal:  Am J Pathol       Date:  2008-07-03       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.